Article
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Therapeutic drug monitoring - 1 Aug 2005
Bondolfi Guido, Morel Françoise, Crettol Séverine, Rachid Fady, Baumann Pierre, Eap Chin B
Abstract excerpt
Clozapine, an atypical antipsychotic, depends mainly on cytochrome P4501A2 (CYP1A2) for its metabolic clearance. CYP1A2 is inducible by smoking, and lower plasma concentrations of clozapine are measured in smokers than in nonsmokers. Case reports have been published on the effects of discontinuing smoking in patients receiving clozapine, which might lead to elevated plasma concentrations and severe side effects....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
